MX368853B - Composiciones y métodos tópicos para el tratamiento de heridas. - Google Patents

Composiciones y métodos tópicos para el tratamiento de heridas.

Info

Publication number
MX368853B
MX368853B MX2016017403A MX2016017403A MX368853B MX 368853 B MX368853 B MX 368853B MX 2016017403 A MX2016017403 A MX 2016017403A MX 2016017403 A MX2016017403 A MX 2016017403A MX 368853 B MX368853 B MX 368853B
Authority
MX
Mexico
Prior art keywords
pharmaceutical composition
relates
topical pharmaceutical
treating
methods
Prior art date
Application number
MX2016017403A
Other languages
English (en)
Other versions
MX2016017403A (es
Inventor
CHACON Enrique
J Saenz Xavier
Original Assignee
CHACON Enrique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHACON Enrique filed Critical CHACON Enrique
Publication of MX2016017403A publication Critical patent/MX2016017403A/es
Publication of MX368853B publication Critical patent/MX368853B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Dispersion Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

En varias modalidades, la presente invención se refiere a una composición farmacéutica tópica para tratar un padecimiento de piel, que comprende una combinación de agentes, en donde la combinación incluye: a) uno o más compuestos antimicrobianos; b) uno o más oligoelementos; c) uno o más elementos de reconstrucción de tejidos; y d) uno o más analgésicos, y un portador farmacéuticamente aceptable. En ciertas modalidades, la invención se refiere a una composición farmacéutica tópica que comprende: sulfadiazina de plata, zinc, óxido, lidocaína, bacitracina, neomicina (por ejemplo, sulfato de neomicina), polimixina B (por ejemplo sulfato de polimixina B), vitamina E y Coenzima Q10. En otras modalidades, la invención se refiere a un método para tratar un padecimiento de piel en un sujeto en necesidad de ello, que comprende administrar al sujeto una cantidad terapéuticamente efectiva de una composición farmacéutica de la invención.
MX2016017403A 2014-07-01 2015-06-26 Composiciones y métodos tópicos para el tratamiento de heridas. MX368853B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462019644P 2014-07-01 2014-07-01
PCT/US2015/037977 WO2016003798A1 (en) 2014-07-01 2015-06-26 Topical compositions and methods for treating wounds

Publications (2)

Publication Number Publication Date
MX2016017403A MX2016017403A (es) 2017-04-27
MX368853B true MX368853B (es) 2019-10-18

Family

ID=55019851

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016017403A MX368853B (es) 2014-07-01 2015-06-26 Composiciones y métodos tópicos para el tratamiento de heridas.

Country Status (7)

Country Link
US (2) US20170136086A1 (es)
EP (1) EP3164139B1 (es)
KR (1) KR20170018852A (es)
CN (1) CN106659733A (es)
CA (1) CA2953785A1 (es)
MX (1) MX368853B (es)
WO (1) WO2016003798A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9795633B2 (en) 2015-06-17 2017-10-24 Margaret Jean Profet Topical and oral formulations comprising taurine and magnesium for the prevention and treatment of acne
CN106075394A (zh) * 2016-06-15 2016-11-09 浙江日升昌药业有限公司 一种软膏制剂以及其制备方法和应用
CN107648589A (zh) * 2017-11-28 2018-02-02 苏州汇涵医用科技发展有限公司 一种皮肤修复凝胶及其制备方法
CN108339149A (zh) * 2018-04-27 2018-07-31 泰州市榕兴医疗用品股份有限公司 一种含维他命e的水凝胶敷料的制备方法
CN112121146B (zh) * 2019-06-25 2021-08-06 山东瑞安药业有限公司 一种用于皮肤创伤的外用凝胶剂及其制备方法
US11951199B1 (en) 2020-08-25 2024-04-09 Rivercrest, LLC Personal skincare product
US20220378747A1 (en) * 2021-05-28 2022-12-01 Timothy L. Kelley Topical composition for treating skin wounds
KR20240120380A (ko) * 2023-01-31 2024-08-07 아주대학교산학협력단 신규한 히스톤탈아세틸화 효소 억제용 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6656928B1 (en) * 1999-09-02 2003-12-02 Mccadden Michael E. Composition for the topical treatment of rashes, dermatoses and lesions
US20040076671A1 (en) * 2002-10-21 2004-04-22 Aletha Tippett Methods and compositions for topical wound treatment
US20080206161A1 (en) * 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
US20040247686A1 (en) * 2003-04-04 2004-12-09 Boehringer Ingelheim International Gmbh Pharmaceutical compositions comprising epinastine for the treatment of skin diseases
AU2006311518B2 (en) * 2005-11-07 2013-01-31 Jaleva Pharmaceuticals, Llc Film-forming resins as a carrier for topical application of pharmacologically active agents
EP2070531B1 (en) * 2007-12-10 2019-08-07 ITALFAR S.r.l. Pharmaceutical preparation containing histamine H2-receptor antagonists having wound healing activity at low doses
US20130245575A1 (en) * 2012-03-14 2013-09-19 Sara Jo Griffin Body product and method of delivery

Also Published As

Publication number Publication date
CN106659733A (zh) 2017-05-10
US20190216886A1 (en) 2019-07-18
CA2953785A1 (en) 2016-01-07
EP3164139B1 (en) 2020-02-12
MX2016017403A (es) 2017-04-27
WO2016003798A1 (en) 2016-01-07
EP3164139A4 (en) 2017-05-10
EP3164139A1 (en) 2017-05-10
KR20170018852A (ko) 2017-02-20
US20170136086A1 (en) 2017-05-18

Similar Documents

Publication Publication Date Title
MX368853B (es) Composiciones y métodos tópicos para el tratamiento de heridas.
PH12015501576A1 (en) Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith
WO2013122932A3 (en) Topical use of a skin-commensal prebiotic agent and compositions containing the same
NZ631701A (en) Apoptosis-including agents for the treatment of cancer and immune and autoimmune diseases
NZ702087A (en) Pharmaceutical compositions and treatment of mastitis
PH12016500356A1 (en) Nsaid and sigma receptor ligand combinations
PH12016501732A1 (en) Formulation for soft anticholinergic analogs
PH12016500140A1 (en) Heterobicycloaryl rorc2 inhibitors and methods of use thereof
PH12016501095A1 (en) Gabapentinoids and sigma receptor ligands combinations
MX2015011316A (es) Imidazopiridazinas sustituidas.
EA201401031A1 (ru) Полутвёрдая композиция для местного применения, которая содержит пирфенидон и модифицированный диаллилдисульфид оксид (m-ddo) для удаления или предупреждения угрей
WO2015066302A3 (en) Compositions, methods of use, and methods of treatment
NZ702415A (en) Methods for treating neutropenia using retinoid agonists
EP2910247A4 (en) COMPOSITIONS FOR PREVENTING OR TREATING ALLERGIC SKIN DISORDERS CONTAINING GPCR19 AGENTS AS ACTIVE INGREDIENTS
MX2017008234A (es) Nuevos complejos metalicos de nocardamina y su uso en composiciones farmaceuticas.
WO2015085055A3 (en) Methods of treating or preventing pruritis by blocking natriuretic polypeptide b
MY182591A (en) Compositions for use in treating eye disorders using dipyridamole
MX356102B (es) Compuestos y métodos para tratar leucemia.
BR112012028409A2 (pt) método para produzir pleurodese em um sujeito mamífero e kit.
BR112015000186A2 (pt) utilização de coceth sulfato de zinco como agente antibacteriano face o propionibacterium acnes
WO2015027121A3 (en) Cancer treatment
WO2012123924A3 (en) Antimicrobial composition including at least one or more aggregation(s) silver particles
MX2018015240A (es) Composiciones que comprenden timolol y su uso en el tratamiento de rosacea mediante administracion topica.
MX2018003308A (es) Suministro localizado de agente anti-fuctactico para tratamiento del cancer.
NZ713046A (en) Therapeutic compositions for the treatment and prevention of gastrointestinal cancer

Legal Events

Date Code Title Description
FG Grant or registration